The Anti-HIV Microbicide Candidate RC-101 Inhibits Pathogenic Vaginal Bacteria Without Harming Endogenous Flora or Mucosa

American Journal of Reproductive Immunology

Volumn 69, Issue 2, 2013, Pages 150-158

  Eade, Colleen R ^a   Cole, Amy L ^a   Diaz, Camila ^a   Rohan, Lisa C ^b,c   Parniak, Michael A ^d   Marx, Preston ^e   Tarwater, Patrick M ^f   Gupta, Phalguni ^b   Cole, Alexander M ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Bacterial Vaginosis; Lactobacilli; RC 101; Theta defensin; Vaginal microbicide

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DEFENSIN; MICROBICIDE; RC 101; UNCLASSIFIED DRUG; PEPTIDE;

ARTICLE; BACTERIUM CULTURE; HUMAN; HUMAN CELL; LACTOBACILLUS; NONHUMAN; PRIORITY JOURNAL; VAGINA FLORA; VAGINA MUCOSA; VAGINITIS; DRUG EFFECTS; FEMALE; GARDNERELLA VAGINALIS; HELA CELL LINE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOBILUNCUS; PATHOGENICITY; PREVOTELLA; SYMBIOSIS; VAGINA; VAGINOSIS, BACTERIAL;

ANTI-HIV AGENTS; FEMALE; GARDNERELLA VAGINALIS; HELA CELLS; HUMANS; LACTOBACILLUS; MICROBIAL SENSITIVITY TESTS; MOBILUNCUS; PEPTIDES; PREVOTELLA; SYMBIOSIS; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84872263951     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12036     Document Type: Article

References (36)

1. WHO, UNICEF, UNAIDS: Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. http://www.who.int/hiv/pub/progress_report2011/en/index.html (23 May 2012, date last accessed).
2. Eade CR, Wood MP, Cole AM: Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development. Curr HIV Res 2012; 10:61-72.
3. Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, Sirivongrangson P, Mukenge-Tshibaka L, Ettiègne-Traoré V, Uaheowitchai C, Karim SS, Mâsse B, Perriëns J, Laga M: COL-1492 study group: effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360:971-977.
4. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J: HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350:546-550.
5. Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y, Li L, Nelson KE, Xia Y, Xiang C: Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics 2010; 11:488.
6. Meltzer MC, Desmond RA, Schwebke JR: Association of Mobiluncus curtisii with recurrence of bacterial vaginosis. Sex Transm Dis 2008; 35:611-613.
7. Eade CR, Diaz C, Wood MP, Anastos K, Patterson BK, Gupta P, Cole AL, Cole AM: identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay. PLoS One 2012. In Press.
8. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB: Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 1989; 86:5974-5978.
9. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS: Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008; 22:1493-1501.
10. Nguyen TX, Cole AM, Lehrer RI: Evolution of primate theta-defensins: a serpentine path to a sweet tooth. Peptides 2003; 24:1647-1654.
11. Cole AM, Hong T, Boo LM: Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci USA 2002; 99:1813-1818.
12. Lamers RP, Eade CR, Waring AJ, Cole AL, Cole AM: Characterization of the retrocyclin analogue RC-101 as a preventative of Staphylococcus aureus nasal colonization. Antimicrob Agents Chemother 2011; 55:5338-5346.
13. Münk C, Wei G, Yang OO, Waring AJ, Wang W, Hong T, Lehrer RI, Landau NR, Cole AM: The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses 2003; 19:875-881.
14. Gupta P, Lackman-Smith C, Snyder B, Ratner D, Rohan L, Patton D, Ramratnam B, Cole A: Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1. In Press: AIDS Res Hum Retroviruses 2012. In press
15. Venkataraman N, Cole AL, Ruchala P, Waring AJ, Lehrer RI, Stuchlik O, Pohl J, Cole AM: Reawakening retrocyclins: ancestral human defensins active against HIV-1. PLoS Biol 2009; 7:e95.
16. Gupta P, Ratner D, Ding M, Patterson B, Rohan LC, Reinhart TA, Ayyavoo V, Huang X, Patton DL, Ramratnam B, Cole AM: Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture. J Aquir Immune Defic Syndr 2012; 60: 455-461.
17. Cole AM, Patton DL, Rohan LC, Cole AL, Cosgrove-Sweeney Y, Rogers NA, Ratner D, Sassi AB, Lackman-Smith C, Tarwater P, Ramratnam B, Ruchala P, Lehrer RI, Waring AJ, Gupta P: The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques. PLoS ONE 2010; 5:e15111.
18. Patton DL, Sweeney YC, Tsai C-C, Hillier SL: Macaca fascicularis vs. Macaca nemestrina as a model for topical microbicide safety studies. J Med Primatol 2004; 33:105-108.
19. Spiegel CA: Susceptibility of Mobiluncus species to 23 antimicrobial agents and 15 other compounds. Antimicrob Agents Chemother 1987; 31:249-252.
20. Tanaka K, Kato N, Watanabe K: In vitro activity of an evernimicin derivative, SCH27899, against anaerobic bacteria and Propionibacterium acnes. J Antimicrob Chemother 2000; 46:465-469.
21. Lopes Dos Santos Santiago G, Grob P, Verstraelen H, Waser F, Vaneechoutte M: Susceptibility testing of Atopobium vaginae for dequalinium chloride. BMC Res Notes 2012; 5: 151.
22. Tran D, Tran PA, Tang Y, Yuan J, Cole T, Selsted ME: Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J Biol Chem 2001; 277:3079-3084.
23. Hillier S, Krohn MA, Watts DH, Wolner-Hanssen P, Eschenbach D: Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990; 76:407-413.
24. Lopes Dos Santos Santiago G, Cools P, Verstraelen H, Trog M, Missine G, Aila N, Verhelst R, Tency I, Claeys G, Temmerman M, Vaneechoutte M: Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles. PLoS ONE 2011; 6: e28180.
25. Zhang R, Daroczy K, Xiao B, Yu L, Chen R, Liao Q: Qualitative and semiquantitative analysis of Lactobacillus species in the vaginas of healthy fertile and postmenopausal Chinese women. J Med Microbiol 2012; 61:729-739.
26. Van Damme L, Govinden R, Mirembe FM, Guédou F, Solomon S, Becker ML, Pradeep BS, Krishnan AK, Alary M, Pande B, Ramjee G, Deese J, Crucitti T, Taylor D: CS study group: lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359:463-472.
27. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ: Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol 1987; 139:788-793.
28. Geiser T, Dewald B, Ehrengruber MU, Clark-Lewis I, Baggiolini M: The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J Biol Chem 1993; 268:15419-15424.
29. Yadav A, Saini V, Arora S: MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010; 411:1570-1579.
30. Proost P, Wuyts A, Van Damme J: Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol 1996; 59:67-74.
31. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S: The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011; 1813:878-888.
32. Rane SG, Reddy EP: Janus kinases: components of multiple signaling pathways. Oncogene 2000; 19:5662-5679.
33. Hayden MS, Ghosh S: Shared principles in NF-kappaB signaling. Cell 2008; 132:344-362.
34. Raman M, Chen W, Cobb MH: Differential regulation and properties of MAPKs. Oncogene 2007; 26:3100-3112.
35. Huang HW: Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 2006; 1758:1292-1302.
36. Aroutcheva A, Ling Z, Faro S: Prevotella bivia as a source of lipopolysaccharide in the vagina. Anaerobe 2008; 14:256-260.